State legislatures across the country are passing laws at a breakneck pace, often with the best intentions: lower drug costs, increase transparency, and protect patients from perceived abuses by pharmacy benefit managers (PBMs). But good intentions alone are not enough. Time and again, well-meaning legislation creates unintended consequences that leave the very communities lawmakers claim to protect—particularly rural Americans—worse off.
Rural communities are uniquely vulnerable in today’s healthcare system. They rely on independent pharmacies for access to life-saving medications and personalized care. When state laws impose rigid restrictions on PBMs, aiming to curb their influence or increase transparency, the immediate effect can be disruptive. PBMs play a vital role in negotiating drug prices and ensuring supply chains remain efficient. Overly restrictive rules can disincentivize PBMs from working in small or low-volume markets, leaving rural pharmacies—and their patients—struggling to get critical medications on time.
We’ve already seen this happen in multiple states. New reimbursement rules and caps on PBM contracts, intended to protect independent pharmacies, have instead led to pharmacy closures and reduced service in remote communities. Patients must travel farther for prescriptions, face higher costs, or wait longer for essential medications. In some cases, local health providers have reported shortages of critical drugs because PBMs can no longer efficiently manage distribution under restrictive state mandates. What was intended to improve healthcare accessibility has inadvertently harmed the very people it was meant to protect.
The problem is predictable. Lawmakers, often under political pressure or responding to national headlines, draft legislation without fully understanding the operational complexities of the pharmacy ecosystem. PBMs, for all their criticisms, are key players in maintaining affordability and supply consistency. When states pass blanket regulations without input from the full spectrum of stakeholders—including rural providers and patients—the result is a policy that looks good on paper but falls short in practice.
Too often, this confusion is amplified by media personalities who oversimplify complex healthcare dynamics. Figures like Marty Makary and Vinay Prasad have positioned themselves as contrarian “experts,” but their commentary routinely overlooks the realities facing rural providers and patients. They offer sweeping critiques of PBMs without acknowledging the operational challenges that rural pharmacies already face or the ways poorly structured legislation can make those challenges worse. Their narratives may draw attention online, but they do little to help the communities that depend on a stable, functioning pharmacy network.
Worse, their sound-bite-driven approach has helped fuel state-level proposals that look good in headlines but collapse under real-world conditions. Makary and Prasad rarely grapple with the consequences of these policies—the pharmacy closures, delayed medication access, and rising costs that disproportionately hit rural families. Instead of working toward practical solutions grounded in data, they lean into oversimplified talking points that mislead lawmakers and distort the policy debate. At a time when rural America needs thoughtful, evidence-based reforms, their commentary pushes states toward decisions that inadvertently undermine patient access and destabilize local healthcare systems.
This is not a call to defend PBMs unconditionally. Oversight, accountability, and transparency are necessary in every sector of healthcare. But policy must be balanced and informed, recognizing the unintended ripple effects that poorly designed laws can have on rural America. Protecting patients requires more than reactive legislation—it requires collaboration, foresight, and an understanding of how every piece of the healthcare system interacts.
The consequences are real. Small-town Americans, already struggling with limited access to healthcare, are left to navigate a patchwork system in flux. Pharmacies close, prescription timelines stretch, and families bear the cost in money, time, and, most importantly, health. Rural communities should not pay the price for legislation that prioritizes optics over outcomes.
Lawmakers must pause, consult, and evaluate. True reform comes from careful analysis, not political theater. States should work with PBMs, independent pharmacies, hospitals, and patient advocates to design policies that lower costs and increase access without destabilizing rural healthcare networks. Oversight is necessary—but so is practicality.
Our rural communities deserve better than well-intentioned laws that backfire. If states truly want to protect patients, legislation must focus on outcomes, not headlines. By ensuring that reforms are thoughtful, collaborative, and evidence-based, we can safeguard access, support rural pharmacies, and put patients—not politics—first.
